Impact of Decitabine Conditioning on Allo‐HSCT Outcomes in AML and Intermediate‐to‐High‐Risk MDS Patients in Remission

ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) remains the sole curative option for myeloid malignancies, though high toxicity from conditioning regimens and complications like graft‐versus‐host disease (GVHD) limit its success. The potential benefit of incorporat...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Shuling Yu, Wanchuan Zhuang, Shengfa Gao, Tongyu Li, Xiao Yan, Guifang Ouyang, Ping Zhang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2025-07-01
coleção:	Cancer Medicine
Assuntos:	allogenic hematopoietic stem cell transplantation AML decitabine graft‐versus‐host disease MDS
Acesso em linha:	https://doi.org/10.1002/cam4.71081
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!